Illumina Inc (ILMN)

ILMN (NASDAQ:Drugs) EQUITY
$138.70
pos +0.00
+0.00%
Today's Range: 0.00 - 0.00 | ILMN Avg Daily Volume: 2,208,600
Last Update: 02/10/16 - 3:59 PM EST
Volume: 0
YTD Performance: -27.33%
Open: $0.00
Previous Close: $138.70
52 Week Range: $130.00 - $242.37
Oustanding Shares: 146,400,000
Market Cap: 20,421,336,000
6-Month Chart
TheStreet Ratings Grade for ILMN
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 9 9 10 10
Moderate Buy 0 0 0 0
Hold 10 10 8 8
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 2.05 2.05 1.89 1.89
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: 42.02
Price Earnings Comparisons:
ILMN Sector Avg. S&P 500
42.02 45.10 27.19
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
-9.78% -27.86% 174.15%
GROWTH 12 Mo 3 Yr CAGR
Revenue 31.00 0.93 0.24
Net Income 29.40 2.02 0.44
EPS 30.50 1.59 0.37
Earnings for ILMN:
EBITDA 0.60B
Revenue 2.22B
Average Earnings Estimates
Qtr (03/16) Qtr (06/16) FY (12/16) FY (12/17)
Average Estimate $0.79 $0.88 $3.61 $4.30
Number of Analysts 15 13 14 14
High Estimate $0.88 $0.96 $3.70 $4.55
Low Estimate $0.70 $0.83 $3.56 $4.05
Prior Year $0.91 $0.80 $3.32 $3.61
Growth Rate (Year over Year) -12.89% 9.71% 8.67% 19.26%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
Bearish
Feb 04, 2016 | 6:57 AM EST
ILMN was downgraded to Hold, Canaccord Genuity said. Valuation call, based on a $160 price target. 
Bearish
Jan 07, 2016 | 7:23 AM EST
ILMN was downgraded from Outperform to Market Perform, Wells Fargo said. Valuation call, as the stock is valued at 48x expected 2016 ea...

This Laggard Is Set to Shine Real Money Pro($)

Illumina is moving toward higher ground.
Charts show ILMN is close to offering a great profit opportunity.

Novice Trade: Illumina Real Money Pro($)

ILMN's three-month at-the-money implied volatility is at about the median level.
With very low oversold readings and a possible reversal pattern, we would at least cover shorts, and would consider probing the long side.
The five-day market win streak stalled a bit today. Though the close was weak, I still give the win to the bulls because of the modest drop in the averages after an 80-handle rise in the S&P index. That said, there was less than meets the eye as, taking out the share price gains of DuPont (DD) and Chevron (CVX), the market would have produced a less-stellar day. A lot of dead-cat bounces, me thinks! Remember Bob Farrell's lesson -- that when the laggards lead, it's typically a worrisome signpost. Energy and biotech caught bids and might be ripe for a near-term rally, albeit from low levels. Banks unchanged. Bonds closed at the day's highs; municipals and our closed-end muni funds were well-bid. Junk was up for a change! Crude was better. The U.S. dollar was a tad weaker. A technician's field day - Doji, evening stars and three peaks and a domed house!  I will be interested if the bullish investor sentiment rises a lot in this week's surveys; I suspect so! We are setting up for an interesting earnings season, even more than usual considering the crosswinds and headwinds.  If big misses at Yum! Brands (YUM), Adobe Systems (ADBE), Illumina (ILMN) and DuPont foreshadow a very weak third-quarter earnings season (and poor forward guidance), you want to be "all in" short, in my view. I sold Oaktree Capi
This move in health care takes your breath away.
Take advantage of elevated option premiums to gain long exposure to biotech.
With such a commanding lead in the sequencing business the stock can't stay down for long.

Columnist Conversations

Juniper appears headed for a re test of major support near its 2015 low. With today's 1.5% loss JNPR is ...
$550 million to buy.
Spooking the markets now.
SPY $185.75 IWM $96.24

REAL MONEY'S BEST IDEAS

News Breaks

Powered by

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.